These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

479 related items for PubMed ID: 14673877

  • 1. Role of dopamine transporter imaging in routine clinical practice.
    Marshall V, Grosset D.
    Mov Disord; 2003 Dec; 18(12):1415-23. PubMed ID: 14673877
    [Abstract] [Full Text] [Related]

  • 2. [Nuclear neuroimaging of dopamine transporter in Parkinsonism--role in routine clinical practice].
    Cohenpour M, Golan H.
    Harefuah; 2007 Sep; 146(9):698-702, 733. PubMed ID: 17969308
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clinical impact of diagnostic SPET investigations with a dopamine re-uptake ligand.
    Løkkegaard A, Werdelin LM, Friberg L.
    Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1623-9. PubMed ID: 12458397
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism.
    Booij J, Speelman JD, Horstink MW, Wolters EC.
    Eur J Nucl Med; 2001 Mar; 28(3):266-72. PubMed ID: 11315592
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Dopamine transporter binding in chronic manganese intoxication.
    Huang CC, Weng YH, Lu CS, Chu NS, Yen TC.
    J Neurol; 2003 Nov; 250(11):1335-9. PubMed ID: 14648150
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Imaging of dopamine transporter with Tc99m-Trodat-SPECT in movement disorders].
    Kanyó B, Argyelán M, Dibó G, Szakonyi Z, Vécsei L, Fülöp F, Láncz A, Forgács P, Pávics L.
    Ideggyogy Sz; 2003 Jul 20; 56(7-8):231-40. PubMed ID: 12971118
    [Abstract] [Full Text] [Related]

  • 14. Normal dopamine transporter binding in dopa responsive dystonia.
    Huang CC, Yen TC, Weng YH, Lu CS.
    J Neurol; 2002 Aug 20; 249(8):1016-20. PubMed ID: 12195447
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinical impact of correlative [123I]-FP-CIT brain imaging and neurological findings in suspect Parkinson's disease.
    Covelli EM, Brunetti A, Di Lauro A, Sullo P, Mazzarella G, Tedeschi E, Belfiore G.
    Radiol Med; 2004 Oct 20; 108(4):417-25. PubMed ID: 15525895
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Distinct FP-CIT PET patterns of Alzheimer's disease with parkinsonism and dementia with Lewy bodies.
    Chung SJ, Lee YH, Yoo HS, Sohn YH, Ye BS, Cha J, Lee PH.
    Eur J Nucl Med Mol Imaging; 2019 Jul 20; 46(8):1652-1660. PubMed ID: 30980099
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.